CD8 T Cell Intrinsic Role of MicroRNA-17~92 in TCR Signaling
CD8 T Cell Intrinsic Role of MicroRNA-17~92 in TCR Signaling
批准号:
8824047
负责人:
Vandana Kalia
金额:
$7.54万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-12-01 至 2015-11-30
关键词:
3&apos Untranslated RegionsAffinityAlgorithmsAntigensApoptosisAutomobile DrivingBiological ProcessCD27 AntigensCD8B1 geneCandidate Disease GeneCellsCellular biologyCommunicable DiseasesCytotoxic T-LymphocytesDataDevelopmentDoseEffector CellEnvironmentEnzymesEventFoundationsFunding MechanismsGene ExpressionGene Expression RegulationGene TargetingGenesGlobal ChangeGoalsHIVHIV-1Hepatitis C virusImmuneImmune responseImmunityImmunologic MemoryInfectionInvestigationKnowledgeLifeLigandsListeria monocytogenesLymphocyte ActivationMalariaMalignant NeoplasmsMeasuresMediatingMemoryMessenger RNAMicroRNAsMicroarray AnalysisModelingMolecularMycobacterium tuberculosisNegative FindingNuclearNucleotidesPTEN genePathway interactionsPatternPeptidesPhosphorylationPlasmodiumProductionProliferatingProteinsRegulationRegulatory PathwayResearch Project GrantsRoleSignal PathwaySignal TransductionSignaling ProteinSmall RNAStagingT cell differentiationT cell regulationT cell responseT-Cell ActivationT-LymphocyteTCR ActivationTitrationsTranscriptTranslationsTuberculosisTumor Suppressor ProteinsVaccinationVaccine DesignVaccinesViral Load resultbasegenome-widehuman DICER1 proteininhibitor/antagonistkillingsnoveloverexpressionpathogenprotective efficacypublic health relevancereceptorresearch studyresponsetumorvaccine efficacy
中文摘要
描述(由申请人提供):MicroRNAs (miRNAs)是一种小rna(约22个核苷酸),通过抑制蛋白质翻译或降解mRNA转录物来调节基因表达。miRNA基因调控通路是高度进化保守的,通过控制多种生物过程,如细胞信号传导、增殖和凋亡,在免疫细胞发育和功能中发挥着重要作用。我们最近的研究表明,CD8 T细胞的miRNA库是动态的,并且在感染后随着初始细胞被激活并分化为效应细胞和记忆细胞而迅速变化。
英文摘要
DESCRIPTION (provided by applicant): MicroRNAs (miRNAs) are small RNAs (~22 nucleotides) that regulate gene expression by inhibiting protein translation or by degrading mRNA transcripts. The miRNA gene regulatory pathway is highly evolutionarily conserved and is emerging as a major player in immune cell development and function, by controlling a diverse array of biological processes such as cell signaling, proliferation and apoptosis. We have recently shown that the miRNA repertoire of CD8 T cells is dynamic and rapidly changes after infection as naive cells get activated and differentiate into effector cells and then memory cells.
In particular, we found that the miR- 17~92 cluster is highly upregulated in rapidly expanding effector cells, with relatively lower expression in memory-fated (memory precursor effector cells, MPECs) than short-lived effector cell (SLECs) subsets. Consistent with our hypothesis that miR-17~92 may be regulating effector and memory fates, deletion or constitutive expression of miR-17~92 revealed a critical CD8 T cell-intrinsic role of miR-17~92 in driving terminal effector differentiation by promoting proliferation. These studies lay a strong framework for investigating the molecular mechanisms by which miR-17~92 regulates effector and memory fates. Using CD8 T cell-specific gain or loss of expression of miR-17~92, we have compelling preliminary evidence supporting our hypothesis that miR-17~92 decreases the threshold of T cell activation by antigen, thus promoting terminal effector differentiation through excessive stimulation and proliferation: (i) Loss of miR- 17~92 impacts CTL expansion and survival, in a manner that is dependent on systemic levels of antigen; (ii) Inhibitors of T cell signaling (the tumor suppressor protein, PTEN, and inhibitory receptor PD-1) are decreased upon overexpression of miR-17~92; (iii) T cell activation by antigen is enhanced upon overexpression of miR- 17~92. Under the R03 funding mechanism, the goal of this small self-contained research project is to conduct incisive experiments that will definitively evaluate the role of miR-17~92 on T cell signaling threshold in antigen-specific CD8 T cells, and also identify key signaling pathways and proteins that are regulated by miR- 17~92. We will measure TCR sensitivity in our dual model of gain or loss of expression of miR-17~92 using suboptimal antigenic peptide dose as well as altered peptide ligands of varying affinity; we will quantify signal transduction cascades downstream of TCR stimulation upon overexpression or loss of miR-17~92; and we will conduct gene profiling of effector CD8 T cells lacking or overexpressing miR-17~92 during early stages of activation towards potentially identifying novel miR-17~92 targets involved in regulating strength of T cell stimulation, proliferation and terminal effector differentiation. Induction of potent memory CD8 T
cells is an important goal of vaccination. Thus, greater understanding of molecular regulation of effector and memory lineage specification, as resulting from proposed studies, has direct relevance to manipulation of CD8 T cell immunity during tumor outgrowth, infection and vaccination.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bispecific Antibody Therapeutics for Neuroblastoma and Diffuse Midline Glioma
-
批准号:10714915
-
项目类别:
-
资助金额:$86.0万
-
财政年份:2023
-
负责人:Vandana Kalia
-
依托单位:
Immune Aging in Responsiveness to Checkpoint Blockade Immunotherapies
-
批准号:10674256
-
项目类别:
-
资助金额:$40.36万
-
财政年份:2022
-
负责人:Vandana Kalia
-
依托单位:
Differential IL-2 Expression by Effector CD8 T cells and Fate Determination
-
批准号:10047445
-
项目类别:
-
资助金额:$23.25万
-
财政年份:2020
-
负责人:Vandana Kalia
-
依托单位:
Differential IL-2 Expression by Effector CD8 T cells and Fate Determination
-
批准号:10263196
-
项目类别:
-
资助金额:$27.9万
-
财政年份:2020
-
负责人:Vandana Kalia
-
依托单位:
Regulation of CD8 T cell memory by autocrine IL-2
-
批准号:8893289
-
项目类别:
-
资助金额:$7.54万
-
财政年份:2015
-
负责人:Vandana Kalia
-
依托单位:
海外基金